Recent legislative initiatives, technological advances and the financial benefits of electronic pedigrees have engendered a new willingness by pharmaceutical companies to utilize RFID in their battles against counterfeit drugs.
Although HF RFID air-interface protocols operate at a single global frequency, a number of factors hinder the ability of HF tags and readers to achieve interoperability.
When used in conjunction with item-level tagging of drugs and other products, TDSI can protect consumer privacy while raising confidence that customers are getting genuine goods.